|
|
||||||||
Medi-Physics, Inc., Emeryville, California
Correspondence: For reprints contact: H. S. Winchell, MD, 1 Via Oneg, Lafayette, CA 94549.
ABSTRACT
Localization in rat brain of forty iodophenylalkyl amines labeled with I-123 was evaluated in an attempt to develop I-123-labeled amines useful for brain studies. For the amines studied, the highest activity in brain and the brain-to-blood activity ratios ranked p > m > o as related to iodine position on the benzene ring: for alkyl groups the rank order was
-methylethyl > ethyl > methyl > none; for N additions it was single lipophilic group > H > two lipophilic groups. It is suggested that introduction of a halogen into the ring structure of many amines results in greater concentration of the agent in brain than is seen with the nonhalogenated parent compound.
Thirty-four of the forty compounds showed higher rat brain activity, and higher brain-to-blood activity ratios at 5 min than did [123I]-4-iodoantipyrine. Ten of the compounds showed a tenfold or greater brain-to-blood ratio at 5 min than did [123I]-4-iodoantipyrine. We propose that while initial uptake of these agents in the brain is a consequence of their lipophilicity and that such initial uptake may be a measure of perfusion, progressive brain accumulation of these agents is probably a combined consequence of intravascular/extravascular intracerebral pH gradients, favorable brain lipid/aqueous partition coefficients, and the affinity of the agents for high-capacity, relatively nonspecific binding sites for amines located in the brain and/or brain capillary endothelium.
The agent N-isopropyl-p-iodoamphetamine was chosen for further study because, in the rat, it showed high brain activity (1.57%/g) and brain-blood ratio (12.6) at 5 min; these increased to 2.14%/g and 20.7 at 60 min (R isomer) following its intravenous administration.
This article has been cited by other articles:
![]() |
Y. Ayada, Y. Tsuda, T. Takahashi, M. Kitadai, M. Ohkawa, H. Matsuo, and Y. Tsuda Volume of Infarction and Blood Flow in Cerebral Embolism Angiology, March 1, 1997; 48(3): 223 - 228. [Abstract] [PDF] |
||||
![]() |
D. C. Costa Single photon emission tomography (SPET) with 99Tc m-hexamethylpropyleneamineoxime (HMPAO) in research and clinical practice - a useful tool Vascular Medicine, September 1, 1990; 1(2): 179 - 201. [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |